Stay updated on Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page with identical trial information (title, conditions, eligibility criteria, interventions, outcomes, and locations). No core content or data elements were added or removed.
    Difference
    0.4%
    Check dated 2025-10-28T05:18:54.000Z thumbnail image
  3. Check
    31 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.
    Difference
    2%
    Check dated 2025-10-06T16:07:14.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; core page metadata updated to reflect a new release.
    Difference
    0.0%
    Check dated 2025-09-29T10:06:28.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2 and the 'Back to Top' element was removed; this suggests minor updates and a small UI tweak, with no evident changes to core content.
    Difference
    0.1%
    Check dated 2025-09-15T00:25:48.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T20:51:26.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location details, while also removing several cancer-related terms and classifications, which may impact the clarity of the content regarding specific medical conditions.
    Difference
    1%
    Check dated 2025-08-31T12:56:11.000Z thumbnail image

Stay in the know with updates to Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Pembrolizumab in Hepatobiliary Tumors Clinical Trial page.